Dr. Wolf H. Fridman is the Director of the Cordeliers Research Centre and Head of the Department of Immunology, Hôpital Européen Geaorges Pompidou in Paris. Dr. Fridman is an expert in cellular and tumor immunology and the author of more than 300 international publications in these fields. His research interests lay in the structure and function of the cellular receptors for IgG antibodies, the role of cytokines in the control of tumor development and the design of novel strategies for therapeutic vaccination of cancer. Dr. Fridman, M.D., Ph.D., was chairman of the department of clinical biology and head of the laboratory of clinical immunology at the Institut Curie in Paris. He was also commissioner of the French government’s Agence du Medicament, the equivalent of the U.S. Food and Drug Administration. In addition, Fridman has served as chief, cellular immunology group, Institut de Recherches Scientifiques sur le Cancer in Villejuif, France. He received his M.D. from the University of Paris and his Ph.D. from the University Pierre et Marie Curie.
Dr. Arnon Nagler is a Professor of Medicine at the Tel Aviv University, Sackler School of Medicine and the Director of the Division of Hematology, Bone Marrow Transplantation and Cord Blood Bank at Chaim Sheba Medical Center, Tel Hashomer, Israel. Dr. Nagler obtained his medical degree from the Hebrew University, Jerusalem and his M.Sc. in cell biology from the Tel Aviv University, Tel Aviv. Prof. Nagler completed residency at the Hadassah University Hospital and was further trained in Internal Medicine and Hematology at the Rambam Center in Haifa, Israel. Before joining Chaim Sheba Medical Center, Dr. Nagler was Senior Physician in the Hadassah Medical Center Department of Bone Marrow Transplantation and Head of the Israel National Human Umbilical Cord Blood Bank at the Hadassah Medical Center. Before that Dr. Nagler was visiting Scientist at the DNAX Research Institute in California and Research Associate at the Hematology Department of Stanford Medical Center. Dr. Nagler’s major research interests are: cord blood biology, adoptive cell mediated immunotherapy, NK and CTL Activity, transplantation in hemato-oncologic malignancies and the role of Collagen Type I in fibrotic disorders. Dr. Nagler is a member of; the American Society of Hematology, The International Bone Marrow Transplant Registry, the International Cord Blood, the American Association of Blood Banking, the ISCT and other organizations. Dr. Nagler is the author of numerous scientific articles and chapters in medical books.
Stay tuned and get all
the latest updates
© Cure Tech 2016 | All Rights Reserved | Legal Disclaimer